Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06077422
PHASE2/PHASE3

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

The goal of this pilot study is to describe and compare Ultrasound-Guided Erector Spinae Plane (ESP) Blocks using Exparel® (bupivacaine liposome injectable suspension) to Marcaine® (bupivacaine hydrochloride) for pain management and outcomes after cardiac surgeries.

Official title: Randomized Control Trial to Assess the Efficacy of Preoperative Erector Spinae Blocks on Cardiac Surgery Postoperative Outcomes

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-01-11

Completion Date

2027-04-05

Last Updated

2026-02-17

Healthy Volunteers

No

Interventions

DRUG

bupivacaine liposome injectable suspension

Bupivacaine liposome injectable suspension (Exparel) will be administered by ultrasound-guided ESP block, unilaterally if thoracotomy on ipsilateral side, bilaterally if median sternotomy.

DRUG

Bupivacaine Hydrochloride

Bupivacaine HCl (Marcaine) will be administered by ultrasound-guided ESP block, unilaterally if thoracotomy on ipsilateral side, bilaterally if median sternotomy.

Locations (1)

Rutgers RWJMS

New Brunswick, New Jersey, United States